In young girls at risk of early puberty and insulin resistance, the diabetes drug metformin delayed the onset of menstruation and decreased the development of insulin resistance, a risk factor for type 2 diabetes, according to a new study. Getting a first menstrual period before age 12 has been linked to an increased risk of breast cancer.